Larimar Therapeutics Aktie

Larimar Therapeutics für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2P5PP / ISIN: US5171251003

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
31.07.2025 04:18:38

Larimar Prices $60 Mln Public Offering Of 18.75M Shares At $3.20 Each

(RTTNews) - Larimar Therapeutics (LRMR) has priced its underwritten public offering of 18.75 million shares at $3.20 per share, aiming to raise $60 million in gross proceeds.

The company also granted underwriters a 30-day option to purchase an additional 2.81 million shares. The offering is expected to close around July 31, 2025, pending customary conditions.

The net proceeds will be used to advance the development of nomlabofusp and other pipeline candidates, as well as for working capital, research and development, and general corporate purposes.

The offering is being made under an effective shelf registration statement filed with the SEC, with final prospectus documents to be made available on the SEC's website.

Wednesday LRMR closed at $3.57 or 1.1331% higher and traded after hours to close at $3.54 or 0.8403% lower on the NasdaqGM.

Nachrichten zu Larimar Therapeutics Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Larimar Therapeutics Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Larimar Therapeutics Inc Registered Shs 2,70 0,00% Larimar Therapeutics Inc Registered Shs